Alpha 2.0
Login Register
» Authors » Sirinporn Suksawatamnuay

Sirinporn Suksawatamnuay

Explore the profile of Sirinporn Suksawatamnuay including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 101
Followers 0
Related Specialties
General Medicine
Science
Biology
Top 10 Co-Authors
Piyawat Komolmit
Kessarin Thanapirom
Panarat Thaimai
Yong Poovorawan
Sombat Treeprasertsuk
Supachaya Sriphoosanaphan
Wattana Sukeepaisarnjaroen
Pisit Tangkijvanich
Nunthiya Srisoonthorn
Nipaporn Siripon
Published In
PLoS One
Sci Rep
PeerJ
Asian Pac J Cancer Prev
BMC Gastroenterol
Affiliations
Soon will be listed here.
Recent Articles
11.
Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy
Sriphoosanaphan S, Thanapirom K, Suksawatamnuay S, Thaimai P, Sittisomwong S, Sonsiri K, et al.
BMC Gastroenterol . 2020 Oct; 20(1):346. PMID: 33069226
Background: Vitamin D (VD) is important in hepatic fibrogenesis in animal models and human studies. VD deficiency is associated with liver fibrosis progression. Metabolic dysfunction of the liver, as an...
12.
Association between Vitamin D Receptor Single-Nucleotide Polymorphisms and Colorectal Cancer in the Thai Population: A Case-Control Study
Suksawatamnuay S, Sriphoosanaphan S, Aumpansub P, Aniwan S, Thanapirom K, Tanasanvimon S, et al.
Biomed Res Int . 2020 Jul; 2020:7562958. PMID: 32626760
Vitamin D and its cognate intracellular nuclear receptor, namely, vitamin D receptor (VDR), are involved in the regulation of a variety of body metabolic processes, immune function, and oncogenesis. A...
13.
Pinostrobin suppresses the Ca2+-signal-dependent growth arrest in yeast by inhibiting the Swe1-mediated G2 cell-cycle regulation
Sopanaporn J, Suksawatamnuay S, Sardikin A, Lengwittaya R, Chavasiri W, Miyakawa T, et al.
FEMS Yeast Res . 2020 May; 20(4). PMID: 32401321
Pinostrobin, a flavonoid compound known for its diverse pharmacological actions, including anti-leukemic and anti-inflammatory activities, has been repeatedly isolated by various screenings, but its action mechanism is still obscure. Previously,...
14.
Clinical significance of post-liver transplant hepatitis E seropositivity in high prevalence area of hepatitis E genotype 3: a prospective study
Komolmit P, Oranrap V, Suksawatamnuay S, Thanapirom K, Sriphoosanaphan S, Srisoonthorn N, et al.
Sci Rep . 2020 May; 10(1):7352. PMID: 32355268
High hepatitis E (HEV) seroprevalence has been reported in the general population and in post-liver transplant (LT) cases in several regions, including Thailand, with genotype 3 being a predominant genotype....
15.
Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C
Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Thaimai P, Wasitthankasem R, et al.
PeerJ . 2019 Oct; 7:e7666. PMID: 31565578
Vitamin D receptor (VDR) modulates host immune responses to infections such as hepatitis C virus (HCV) infection, including interferon signaling. This study aimed to investigate the associations of VDR polymorphisms...
16.
Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study
Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Treeprasertsuk S, Tanwandee T, Charatcharoenwitthaya P, et al.
Asian Pac J Cancer Prev . 2019 Apr; 20(4):1257-1264. PMID: 31030503
Background: Vitamin D deficiency is related to poor clinical outcomes in patients with chronic hepatitis B virus (HBV) infection. Methods: We aimed to investigate the association between the genetic variants...
17.
Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study
Komolmit P, Kimtrakool S, Suksawatamnuay S, Thanapirom K, Chattrasophon K, Thaimai P, et al.
Sci Rep . 2017 Aug; 7(1):8905. PMID: 28827788
Hepatic fibrosis is the net accumulation of matrix tissue components which controlled by pro-fibrolytic enzymes, matrix metalloproteinases (MMPs), and pro-fibrotic cytokine, TGF-β, and enzymes, tissue inhibitors of MMPs (TIMPs). Vitamin...
18.
Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: a multicentre study
Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Treeprasertsuk S, Tanwandee T, Charatcharoenwitthaya P, et al.
Antivir Ther . 2017 Jun; 23(1):67-75. PMID: 28635613
Background: Sodium taurocholate co-transporting polypeptide (NTCP) is a cell receptor for HBV. The S267F variant on the NTCP gene is inversely associated with the chronicity of HBV infection, progression to...
19.
Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients
Thanapirom K, Suksawatamnuay S, Sukeepaisarnjaroen W, Tangkijvanich P, Treeprasertsuk S, Thaimai P, et al.
BMC Gastroenterol . 2017 Apr; 17(1):54. PMID: 28415985
Background: Patients with chronic hepatitis C (HCV) infection have high prevalence of vitamin D deficiency. Genome-wide association study data has showed that several genetic variants within vitamin D cascade affect...
20.
Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial
Komolmit P, Charoensuk K, Thanapirom K, Suksawatamnuay S, Thaimai P, Chirathaworn C, et al.
PLoS One . 2017 Apr; 12(4):e0174608. PMID: 28376103
Trial Registration: Thai Clinical Trials Registry TCTR20160429001.